Albemarle Corporation (ALB), a specialty chemicals company with a market cap of $10.7 billion, is set to release its Q3 2025 results on Nov. 5. Analysts expect an adjusted loss of $0.92 per share, a 40.7% improvement from last year. For fiscal 2025, a loss of $1.59 per share is forecasted, up 32.1% from fiscal 2024. Despite a 5.5% stock decline over the past year, Albemarle exceeded Q2 2025 EPS estimates but faced challenges due to falling lithium prices. Analysts maintain a “Hold” rating on ALB stock, with a trading price above the average analyst target of $91.17.

Read more at Yahoo Finance: Albemarle Earnings Preview: What to Expect